Adrenaline (Anaphylaxis Protocol)
Brand names: EpiPen, Emerade, Jext, Auvi-Q
This page concerns adrenaline (epinephrine) used under the anaphylaxis protocol, given by intramuscular injection into the anterolateral thigh as the immediate first-line treatment for anaphylaxis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
By stimulating alpha-1 receptors it reverses vasodilation and reduces mucosal oedema, while beta-1 and beta-2 stimulation supports cardiac output and relieves bronchospasm, counteracting the core features of anaphylaxis.
Prescribing in practice
- In anaphylaxis the route is intramuscular into the anterolateral thigh and must be given without delay; the much more concentrated cardiac-arrest intravenous strength must never be used for intramuscular anaphylaxis treatment.
- Repeat the intramuscular dose after a short interval if there is no improvement, and escalate to senior/critical-care support with consideration of an intravenous infusion only by experienced clinicians.
- Use a children's formulary for age- and weight-appropriate intramuscular dosing in paediatric anaphylaxis.
Monitoring
Monitor airway, breathing, circulation, oxygen saturation and ECG continuously, observing for biphasic reactions after initial recovery.
Counselling the patient
- Adrenaline is the priority treatment; antihistamines and steroids are second-line and must not delay it.
- Advise prolonged observation because symptoms can recur hours later.
- Arrange auto-injector provision, training and allergy follow-up before discharge.
Evidence & guidelines
Intramuscular adrenaline is the cornerstone of anaphylaxis management in Resuscitation Council UK guidance and NICE guideline CG134.
Reference: Resuscitation Council UK Anaphylaxis Algorithm 2021; NICE CG134; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- EDACS — Emergency Department Assessment of Chest Pain · Chest Pain
- ADAPT Protocol for Cardiac Event Risk · Chest Pain
- HIV Needle-Stick Risk Assessment Stratification Protocol (RASP) · HIV Post-Exposure
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Westley Croup Score · Respiratory
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Adrenaline (Anaphylaxis Protocol) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.